Roche to buy gene therapy specialist Spark in $4.3 billion deal
February 25, 2019 at 01:37 AM EST
Roche on Monday said it will buy Spark Therapeutics in a transaction valued at $4.3 billion as the Swiss drugmaker builds its hemophilia portfolio and seeks to keep pace in gene therapy with rivals like Novartis.
